Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Use-result Survey to Assess the Safety and Efficacy of the Combination of Tacrolimus + Biological Agents in Daily Clinical Settings

NCT01870908 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT01870908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01870908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Use-result Survey to Assess the Safety and Efficacy of the Combination of Tacrolimus + Biological Agents in Daily Clinical Settings
Lead sponsor
Astellas Pharma Inc
Phase
Observational
Overall status
Completed
Start date
August 31, 2012
Completion date
March 31, 2015
Enrollment
664 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis